Covered recipient · General Payments record
ERICA L LAMPKIN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2020–2024
$2,714.62
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,215.26 | 53 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $153.11 | 3 |
| Acerta Pharma LLC | $150.82 | 8 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $125.93 | 6 |
| Daiichi Sankyo Inc. | $76.93 | 3 |
| TAIHO ONCOLOGY, INC. | $76.64 | 3 |
| Ipsen Biopharmaceuticals, Inc | $71.66 | 2 |
| Alexion Pharmaceuticals, Inc. | $58.61 | 3 |
| PFIZER INC. | $56.62 | 3 |
| Merck Sharp & Dohme Corporation | $52.44 | 2 |
| Incyte Corporation | $45.93 | 2 |
| Coherus Biosciences Inc. | $30.04 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $29.41 | 1 |
| EISAI INC. | $26.98 | 1 |
| Exelixis Inc. | $24.78 | 1 |
| Gilead Sciences, Inc. | $23.47 | 1 |
| Lilly USA, LLC | $20.81 | 1 |
| PharmaEssentia USA Corporation | $20.07 | 1 |
| JAZZ PHARMACEUTICALS INC. | $19.13 | 1 |
| SpringWorks Therapeutics, Inc. | $19.08 | 1 |
| ARRAY BIOPHARMA INC | $18.59 | 1 |
| Stemline Therapeutics Inc. | $17.80 | 1 |
| Karyopharm Therapeutics Inc. | $17.73 | 1 |
| Fresenius Kabi USA, LLC | $17.32 | 1 |
| BeiGene USA, Inc. | $16.49 | 1 |
| GlaxoSmithKline, LLC. | $15.35 | 1 |
| Genentech USA, Inc. | $14.97 | 1 |
| Astellas Pharma US Inc | $14.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.